Moleculin Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 1.25 M | $1.22 M | 293.59% | 13.38% |
| CETERA INVESTMENT ADVISERS | 05/06/2025 | 70.00 K | $68.15 K | 100.00% | 0.75% |
| LPL FINANCIAL LLC | 05/07/2025 | 46.08 K | $44.86 K | 11.80% | 0.49% |
| VANGUARD GROUP INC | 05/09/2025 | 30.94 K | $30.13 K | 0.00% | 0.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 26.06 K | $25.38 K | 18.31% | 0.28% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 12.78 K | $12.00 K | 100.00% | 0.14% |
| BLACKROCK, INC. | 05/02/2025 | 12.38 K | $12.05 K | 0.00% | 0.13% |
| XTX TOPCO LTD | 05/08/2025 | 11.58 K | $11.27 K | 100.00% | 0.12% |
| TRUIST FINANCIAL CORP | 04/29/2025 | 10.50 K | $10.22 K | 0.00% | 0.11% |
| CITIGROUP INC | 05/12/2025 | 2.79 K | $2.71 K | 100.00% | 0.03% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/15/2025 | 1.37 K | $1.33 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.35 K | $1.31 K | -66.50% | 0.01% |
| MORGAN STANLEY | 05/15/2025 | 926 | $901 | 117.37% | 0.01% |
| 05/02/2025 | 746 | $726 | 84.20% | 0.01% | |
| BOGART WEALTH, LLC | 05/02/2025 | 300 | $292 | 0.00% | 0.00% |
| SANDY SPRING BANK | 05/12/2025 | 89 | $87 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 43 | $41 | -12.24% | 0.00% |
| FMR LLC | 05/12/2025 | 34 | $33 | 100.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 04/16/2025 | 34 | $33 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 32 | $31 | -69.23% | 0.00% |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 04/17/2025 | 17 | $17 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ATTICUS WEALTH MANAGEMENT, LLC | 04/22/2025 | 0 | $0 | -100.00% | 0.00% |
| KESTRA INVESTMENT MANAGEMENT, LLC | 05/16/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Moleculin Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Moleculin Biotech, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.25 M
Cetera Investment Advisers: 70,000
LPL Financial LLC: 46,080
VANGUARD GROUP INC: 30,935
GEODE CAPITAL MANAGEMENT, LLC: 26,057
Cambridge Investment Research Advisors, Inc.: 12,781
15.82% of Moleculin Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.49 M shares in the last 24 months. This purchase volume represents approximately $994.41 K in transactions.